Gallium (68Ga) Chloride — Drug Intelligence | 14 EU Trials

Filter these 14 trials by condition, phase, country and more.

Open in Search →

14 Registered trials

8 Recruiting

3 Completed trials

8 Sponsors

3 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase III: 4 Phase II/III: 1 Phase II: 5 Phase III/IV: 2 Phase IV: 2

Oversight events:

2 temporary halts 1 corrective measure across 3 trials

View oversight register →

Indications tested

Cholangiocarcinoma 1 Neuroendocrine tumour 1 Endometrial cancer stage II 1 Endometrial cancer stage I 1 Crohn's disease 1 Squamous cell carcinoma of the oral cavity 1

Sponsors using this IMP

Amsterdam UMC 3 Centre Hospitalier Universitaire De Bordeaux 3 Universitair Medisch Centrum Utrecht 3 Amsterdam UMC Stichting 1 Centre Hospitalier Regional Et Universitaire De Brest 1 CHU de Brest 1 Radboud universitair medisch centrum Stichting 1 Voxel S.A. 1

All trials

14 total

A clinical study using a radioactive imaging agent with PET-CT to detect neuroendocrine tumors Not authorised

2025-524050-34-01 Phase III 1 country Voxel S.A.
Staging of gastric cancers by PET-FAPI Pending

2025-524434-25-00 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
FAPI-PET value for the initial screening of pancreatic and biliary cancers (FAPDIG Study) Recruiting

2024-517270-23-00 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
The MIRAGE study. Use of radioactively labelled deferoxamine for a novel purpose: imaging pulmonary aspergillosis with PET/CT scans. Recruiting

2023-509744-10-00 Phase II 1 country Radboud universitair medisch centrum Stichting
FARE Trial Recruiting

2023-506594-35-00 Phase IV 1 country Amsterdam UMC
68-Ga-FAPI-46 positron emission tomography (PET) to better visualise pancreatic and bile duct cancer. Recruiting

2024-516486-36-00 Phase II/III 1 country Stichting Amsterdam UMC
68Gallium-FAPI PET/CT imaging in Chronic inflammatory and fibrotic diseases (PARADISE study) Recruiting

2023-508190-84-01 Phase II 1 country CHU de Brest
Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A … Recruiting

2024-514233-37-00 Phase III 1 country Universitair Medisch Centrum Utrecht
FAPi-PET imaging of in vivo early fistula healing in perianal Crohn’s disease: PERSIST study Recruiting

2023-505317-25-00 Phase IV 1 country Amsterdam UMC
Intra-arterial hepatic (IAH) infusion of radiolabelled somatostatin analogs in GEP-NET patients with dominant liver metastases Recruiting

2024-514785-39-00 Phase II 1 country Centre Hospitalier Universitaire De Bordeaux
Screening for occult malignancy using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in patients with … Ended

2024-514703-34-00 Phase III 1 country Centre Hospitalier Regional Et Universitaire De Brest
Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT. Suspended

2025-521682-27-00 Phase III/IV 1 country Universitair Medisch Centrum Utrecht
SENtinel lymph node mapping with GAllium-68-tilmanocept PET/CT in high/high- intermediate risk endometrial cancer: a proof-of-concept study Ended

2024-516708-40-00 Phase III 1 country Universitair Medisch Centrum Utrecht
Unravelling intestinal fibrosis in ulcerative colitis: INTERACT study Ended

2023-507907-73-00 Phase III/IV 1 country Amsterdam UMC

Showing 1–14 of 14 trials

← All drugs A–Z